Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how the Bloomberg Global Innovative Biopharma Index (BGIBT) can help track value creation across the biopharma ecosystem.
Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how the Bloomberg Global Innovative Biopharma Index (BGIBT) can help track value creation across the biopharma ecosystem.